Olivieri O, Stranieri C, Girelli D, Pizzolo F, Grazioli S, Russo C, Pignatti P F, Corrocher R
Department of Clinical and Experimental Medicine, Chair of Internal Medicine, University of Verona, Italy.
J Hypertens. 2001 May;19(5):879-84. doi: 10.1097/00004872-200105000-00007.
Molecular variants of the angiotensinogen (AGT) and the angiotensin II type 1 receptor (ATR) genes have been associated with the risk of coronary artery disease (CAD) and myocardial infarction (MI), but data so far available are conflicting. The primary object of the paper is to verify this possible association by a rigorous, angiographically controlled study in a large sample of patients with or without multi-vessel CAD.
We designed a large case-control study in Italian patients candidates for coronary artery bypass grafting, with angiographically documented multi-vessel CAD, compared to subjects with angiographically documented normal coronary arteries.
AGT M235T and ATR A1166C gene polymorphisms were analysed in 699 subjects; 454 patients were candidates for coronary artery bypass grafting, having angiographically documented (mainly multi-vessel) CAD. An appropriate documentation of previous MI was obtained from 404/454 (89%, 247 with and 157 without MI). Subjects (n = 245) with angiographically documented normal coronary arteries, were included as control group (CAD-free group). CAD patients had a substantial burden of conventional risk factors as compared with controls free of coronary atherosclerosis. Age, gender, smoking habit and number of stenosed vessels were the only differences between patients with or without previous myocardial infarction, who were similarly exposed to the other conventional risk factors (including hypertension). AGT M235T and ATR A1166C allele and genotype frequencies were similar between CAD and CAD-free patients. In the CAD group, AGT 235T allele was found more frequently in subjects with a previous myocardial infarction (0.494 versus 0.414; P < or = 0.05). By logistic regression, homozygosity for AGT 235T variant appeared to confer 1.9-fold increased risk for MI in both the univariate and the multivariate (adjusted for age, gender, smoking habit and number of stenosed vessels) model.
AGT 235 T homozygous patients with multivessel CAD have an increased risk of myocardial infarction as compared with subjects with clinically similar phenotype but different genotype.
血管紧张素原(AGT)基因和血管紧张素II 1型受体(ATR)基因的分子变异与冠状动脉疾病(CAD)和心肌梗死(MI)风险相关,但目前可得的数据相互矛盾。本文的主要目的是通过一项严谨的、经血管造影对照的研究,在大量有或无多支血管CAD的患者样本中验证这种可能的关联。
我们设计了一项大型病例对照研究,研究对象为意大利拟行冠状动脉搭桥术且经血管造影证实有多支血管CAD的患者,并与经血管造影证实冠状动脉正常的受试者进行比较。
对699名受试者的AGT M235T和ATR A1166C基因多态性进行了分析;454名患者拟行冠状动脉搭桥术,经血管造影证实(主要为多支血管)患有CAD。从404/454名患者(89%,247名有MI,157名无MI)中获得了既往MI的适当记录。经血管造影证实冠状动脉正常的受试者(n = 245)作为对照组(无CAD组)。与无冠状动脉粥样硬化的对照组相比,CAD患者有大量传统危险因素。年龄、性别、吸烟习惯和狭窄血管数量是有或无既往心肌梗死患者之间的唯一差异,他们同样暴露于其他传统危险因素(包括高血压)。CAD患者和无CAD患者之间的AGT M235T和ATR A1166C等位基因及基因型频率相似。在CAD组中,AGT 235T等位基因在有既往心肌梗死的受试者中更常见(0.494对0.414;P≤0.05)。通过逻辑回归分析,在单变量和多变量(校正年龄、性别、吸烟习惯和狭窄血管数量)模型中,AGT 235T变异纯合子似乎使MI风险增加1.9倍。
与具有临床相似表型但基因型不同的受试者相比,多支血管CAD的AGT 235T纯合患者发生心肌梗死的风险增加。